innoscripta SE (ISIN: DE000A40QVM8) has broadened its customer base across Europe, with its Clusterix research and development documentation platform now serving clients in 14 countries. The German company announced that during the current financial year, it has signed contracts with businesses in several new markets, including Poland, Romania, Denmark, Finland, Switzerland, Spain, Portugal, Slovakia and the Netherlands. These additions complement its existing customer relationships in Germany, Austria, France, the United Kingdom and the United States.
The expansion addresses a critical challenge for multinational corporations: navigating the diverse regulatory frameworks for R&D tax incentives across Europe. Almost every European country offers tax breaks for research and development, but each has its own instruments and documentation requirements. Companies must demonstrate which employees worked on which projects, when they performed the work, and how much time they spent. Clusterix enables ongoing recording of project hours by employee, day, and project, supported by system-based plausibility checks and monthly approval by project managers. This creates a consistent documentation framework that works across borders, allowing corporate groups with R&D facilities in multiple countries to comply with local tax rules using a single system.
Poland, in particular, represents an attractive growth market for innoscripta. Under the Polish R&D tax relief scheme (ulga B+R), eligible R&D personnel costs can be deducted at a rate of 200%. As in Germany, the Polish Corporate Income Tax Act requires that personnel costs qualify only in proportion to the time actually spent on research and development by each employee each month. Additionally, Polish law explicitly requires R&D costs to be recorded separately in the company's accounting records. Clusterix's monthly, employee-level time tracking enables customers to meet these demanding documentation requirements, positioning the company to capture significant growth in Poland.
Sebastian Schwertlein, COO of innoscripta SE, commented: “We developed Clusterix for the most demanding market we knew: Germany. The fact that customers from different industries in Poland, the Netherlands and Finland are now turning to us demonstrates that this documentation framework works across borders and is fully scalable wherever R&D incentives depend on reliable supporting evidence. Fourteen countries are not an endpoint for us. This is clear evidence that our platform delivers value to businesses across Europe.”
The announcement highlights the growing importance of robust R&D documentation as tax authorities across Europe tighten scrutiny of incentive claims. For businesses engaged in innovation, reliable time-tracking and project management tools like Clusterix can reduce compliance risk and ensure they capture available tax benefits. For innoscripta, the expansion into 14 countries signals strong international demand and positions the company as a pan-European provider of R&D management software.
For more details, the original release is available on www.newmediawire.com and NEWMEDIAWIRE.
